Through a pay-back scheme organized in collaboration with Limburg’s Kankerfonds, InnoSer has recently acquired two new imagers that will enable deeper insights into our in vitro and in vivo platforms available for preclinical oncology research. The first being the ImageXpress Micro 4, a high-content, live cell imaging solution, and the second is the Lumina III In Vivo Imaging System which allows for bioluminescent imaging (BLI) of in vivo models.
ImageXpress Micro 4 –
Lumina III In Vivo Imaging System –
Want to read more?
Total kidney volume (TKV) as a translationally relevant, non-invasive disease progression readout
In this month's newsletter, we invite you to explore how InnoSer's longitudinal total kidney volume (TKV) assessment via non-invasive ultrasound imaging in our ADPKD mouse model provides a clinically aligned structural readout that directly supports decision-making in...
Translational Neuroscience: Comprehensive longitudinal profiling of the Tau[P301S] female vs male mice
In this month’s newsletter, we highlight and build upon our knowledge working with the Tau[P301S] mouse model (originally described by Allen et al., 2002), and its applicability in preclinical research.Female and male...
Clinically relevant biomarker panels for comprehensive efficacy studies in Alzheimer’s Disease mouse models
InnoSer's validated Alzheimer's disease (AD) mouse models are equipped with translationally relevant biomarker readout panels — spanning amyloid-beta (Aβ) species, phosphorylated Tau isoforms, and the early, sensitive hallmark of neurodegeneration, neurofilament light...




![Translational Neuroscience: Comprehensive longitudinal profiling of the Tau[P301S] female vs male mice](https://www.innoserlaboratories.com/wp-content/uploads/2026/06/Female-TauP301S-mice-show-early-spontaneous-hyperactivity-in-automated-home-cages-PhenoTyperTM-229375_400x250.png)
